To explore the potential mechanism of cancer patients appearing more vulnerable to SARS-
CoV-2 infection and poor COVID-19 outcomes, we conducted an integrative bioinformatics …

Background Early research indicates that cancer patients are more vulnerable to adverse
outcomes and mortality when infected with severe acute respiratory syndrome coronavirus 2 …

The SARS-CoV-2 virus, also known as the severe acute respiratory syndrome coronavirus 2,
has raised great threats to humans. The connection between the SARS-CoV-2 virus and …

The outbreak of novel coronavirus disease 2019 (COVID-19) has become the largest health
threat worldwide, with more than 34.40 million positive cases and over 1.02 million deaths …

With the increasing number of immunoinflammatory complexities, cancer patients have a
higher risk of serious disease outcomes and mortality with SARS-CoV-2 infection which is …

We identified 14 immune‐related differentially Expressed Genes (DEGs) between COVID‐
19 patients and normal controls and the receiver operator characteristic curve results …

Background: Cancer patients are alleged to have poor coronavirus disease 2019 (COVID-
19) outcomes. However, no systematic or comprehensive analyses of the role and …

Both lung adenocarcinoma and SARS-CoV-2 infection could cause pulmonary
inflammation. Angiotensin-converting enzyme 2, not only as the functional receptor of SARS …

In 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused
infections worldwide. However, the correlation between the immune infiltration and …

The aberrant expression level of SARS-CoV-2 cell receptor gene ACE2 was reported in lung
adenocarcinoma (LUAD) comorbidity of COVID-19. However, the association of ACE2 …